Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease`
Roche reported the drug sefaxersen achieved statistically significant and clinically meaningful results in a Phase…
Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease`
Roche reported the drug sefaxersen achieved statistically significant and clinically meaningful results in a Phase 3 test in immunoglobulin A nephropathy, or IgAN. This antisense oligonucleotide, which came from Ionis Pharmaceuticals, could offer advantages over other drugs currently available for treating this rare chronic disease of the kidneys. The post Phase 3 Data Could Make…
CMS Administrator Mehmet Oz Discusses AI, Prior Authorization and Innovation
Mehmet Oz shared CMS’s perspective on AI, faster innovation, prior authorization
Addus Paying $275M For AccentCare’s Personal Care Division
CFO Brian Poff told a recent conference that the Texas-based company is looking to strike other significant deals in the near future.
Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device
The Series A round was led by .406 Ventures, with support from Emerson Collective (managed by Yosemite), Forerunner, Serena Ventures and Japan-based MPower Partners. The post Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device appeared first on MedCity News.
Oracle Unveils New Oncology EHR With Embedded AI
Oracle has unveiled a new Oncology EHR designed to bring patient information, AI and clinical decision support together across the cancer care journey
Nevada HIE to Extend Health Data Infrastructure Directly to Consumers
HealtHIE Nevada is working in partnership with b.well Connected Health on HealthRecords Nevada, which is set to launch this fall
Who is Abridge’s CEO Shiv Rao? No, Really…
At the annual South Asian Health Leaders Forum held in Boston last week, Shiv Rao talked candidly about his biography and how it propelled him to build Abridge The post Who is Abridge’s CEO Shiv Rao? No, Really… appeared first on MedCity News.
How UTMB’s Chief AI Officer Views Agents’ Roles in Health System Workflows
Peter McCaffrey, M.D., M.S., chief digital and AI officer at UT Medical Branch, and Bunkerhill Health’s Azita Hamedani, M.D., M.P.H., M.B.A., discuss deployment of an agentic platform
Innovation in Oncology: The Synergy of New and Old Drugs
Years of joint industry-academic engineering suggest that highly engineered single agents will not be the most effective treatments for solid tumors; the solution will be combining the right drugs and administering them in the right way. The post Innovation in Oncology: The Synergy of New and Old Drugs appeared first on MedCity News.
Women’s Health Care Affordability Challenges
As health care costs dominate the national political conversation, our 2026 KFF Women’s Health Survey shows the toll those costs are taking on women. Our new nationally representative survey of women and men ages 18–64 finds costs remain a major barrier for women, specifically — causing everything from delayed care to rationed medications to cuts…
